Chemotherapeutic treatment of bone marrow stromal cells strongly affects their protective effect on acute myeloid leukemia cell survival

References

• Venditti A, Buccisano F, Del Poeta G, Maurillo L, Tamburini A, Cox C, et al. Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia. Blood 2000; 96: 3948–3952
   PubMed Web of Science ®Google Scholar
• San Miguel J F, Vidriales M B, Lopez-Berges C, Díaz-Mediavilla J, Gutiérrez N, Cañizo C, et al. Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification. Blood 2001; 98: 1746–1751
   PubMed Web of Science ®Google Scholar
• Feller N, van der Pol M A, van Stijn A, Weijers G WD, Westra A H, Evertse B W, et al. MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukaemia. Leukemia 2004; 18: 1380–1390
   PubMed Web of Science ®Google Scholar
• Torok-Storb B, Iwata M, Graf L, Gianotti J, Horton H, Byrne M C. Dissecting the marrow microenvironment. Ann N Y Acad Sci 1999; 872: 164–170
   PubMed Web of Science ®Google Scholar
• Shain K H, Dalton W S. Cell adhesion is a key determinant in de novo multidrug resistance (MDR): new targets for the prevention of acquired MDR. Mol Cancer Ther 2001; 1: 69–78
   PubMed Web of Science ®Google Scholar
• Nefedova Y, Landowski T H, Dalton W S. Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms. Leukemia 2003; 17: 1175–1182
   PubMed Web of Science ®Google Scholar
• Cheung W C, Van Ness B. The bone marrow stromal microenvironment influences myeloma therapeutic response in vitro. Leukemia 2001; 15: 264–271
   PubMed Web of Science ®Google Scholar
• Manabe A, Coustan-Smith E, Behm F G, Raimondi S C, Campana D. Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia. Blood 1992; 79: 2370–2377
   PubMed Web of Science ®Google Scholar
• Mudry R E, Fortney J E, York T, Hall B M, Gibson L F. Stromal cells regulate survival of B-lineage leukemic cells during chemotherapy. Blood 2000; 96: 1926–1932
   PubMed Web of Science ®Google Scholar
• Van Stijn A, Kok A, van Stalborch M A, van der Pol M A, Feller N, Westra A H, et al. Minimal residual disease cells in AML patients have an apoptosis sensitive protein profile. Leukemia 2004; 18: 875–877
   PubMed Web of Science ®Google Scholar
• Bendall L J, Daniel A, Kortlepel K, Gottlieb D J. Bone marrow adherent layers inhibit apoptosis of acute myeloid leukemia cells. Exp Hematol 1994; 22: 1252–1260
   PubMed Web of Science ®Google Scholar
• Bradstock K F, Gottlieb D J. Interaction of acute leukemia cells with the bone marrow microenvironment: implications for control of minimal residual disease. Leuk Lymphoma 1995; 18: 1–16
   PubMed Web of Science ®Google Scholar
• Matsunaga T, Takemoto N, Sato T, Takimoto R, Tanaka I, Fujimi A, et al. Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia. Nat Med 2003; 9: 1158–1165
   PubMed Web of Science ®Google Scholar
• Konopleva M, Konoplev S, Hu W, Zaritskey A Y, Afanasiev B V, Andreeff M. Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins. Leukemia 2002; 16: 1713–1724
   PubMed Web of Science ®Google Scholar
• Garrido S M, Appelbaum F R, Willman C L, Banker D E. Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5). Exp Hematol 2001; 29: 448–457
   PubMed Web of Science ®Google Scholar
• Ryningen A, Wergeland L, Glenjen N, Gjertsen B T, Bruserud O. In vitro crosstalk between fibroblasts and native human acute myelogenous leukemia (AML) blasts via local cytokine networks results in increased proliferation and decreased apoptosis of AML cells as well as increased levels of proangiogenic Interleukin 8. Leuk Res 2005; 29: 185–196
   PubMed Web of Science ®Google Scholar
• Hunter A E, Rogers S Y, Roberts I A, Barrett A J, Russell N. Autonomous growth of blast cells is associated with reduced survival in acute myeloblastic leukemia. Blood 1993; 82: 899–903
   PubMed Web of Science ®Google Scholar
• Lowenberg B, van Putten W L, Touw I P, Delwel R, Santini V. Autonomous proliferation of leukemic cells in vitro as a determinant of prognosis in adult acute myeloid leukemia. N Engl J Med 1993; 328: 614–619
   PubMed Web of Science ®Google Scholar
• Banfi A, Bianchi G, Galotto M, Cancedda R, Quarto R. Bone marrow stromal damage after chemo/radiotherapy: occurrence, consequences and possibilities of treatment. Leuk Lymphoma 2001; 42: 863–870
   PubMed Web of Science ®Google Scholar
• Van der Pol M A, Broxterman H J, Westra G, Ossenkoppele G J, Schuurhuis G J. Novel multiparameter flow cytometry assay using Syto16 for the simultaneous detection of early apoptosis and apoptosis-corrected P-glycoprotein function in clinical samples. Cytometry B Clin Cytom. 2003; 55: 14–21
   PubMed Web of Science ®Google Scholar
• Schuurhuis G J, Muijen M M, Oberink J W, de Boer F, Ossenkoppele G J, Broxterman H J. Large populations of non-clonogenic early apoptotic CD34-positive cells are present in frozen-thawed peripheral blood stem cell transplants. Bone Marrow Transplant 2001; 27: 487–498
   PubMed Web of Science ®Google Scholar
• Winter S S, Sweatman J J, Larson R S. Improved quantification of cell survival on stromal monolayers by flow cytometric analyses. Cytometry 2000; 40: 26–31
   PubMedGoogle Scholar
• Tazzari P L, Cappellini A, Grafone T, Mantovani I, Ricci F, Billi A M, et al. Detection of serine 473 phosphorylated Akt in acute myeloid leukaemia blasts by flow cytometry. Br J Haematol 2004; 126: 675–681
   PubMed Web of Science ®Google Scholar
• Zeng Z, Samudio I J, Zhang W, Estrov Z, Pelicano H, Harris D, et al. Simultaneous inhibition of PDK1/AKT and Fms-like tyrosine kinase 3 signaling by a small-molecule KP372-1 induces mitochondrial dysfunction and apoptosis in acute myelogenous leukemia. Cancer Res 2006; 66: 3737–3746
   PubMed Web of Science ®Google Scholar
• Keller U, Gotze K S, Duyster J, Schmidt B, Rose-John S, Peschel C. Murine stromal cells producing hyper-interleukin-6 and Flt3 ligand support expansion of early human hematopoietic progenitor cells without need of exogenous growth factors. Leukemia 2002; 16: 2122–2128
   PubMed Web of Science ®Google Scholar
• Roecklein B A, Torok-Storb B. Functionally distinct human marrow stromal cell lines immortalized by transduction with the human papilloma virus E6/E7 genes. Blood 1995; 85: 997–1005
   PubMed Web of Science ®Google Scholar
• Whetton A D, Dexter T M. Influence of growth factors and substrates on differentiation of haemopoietic stem cells. Curr Opin Cell Biol 1993; 5: 1044–1049
   PubMed Web of Science ®Google Scholar
• Van Stijn A, van der Pol M A, Kok A, Bontje P M, Roemen G M, Beelen R H, et al. Differences between the CD34+ and CD34− blast compartments in apoptosis resistance in acute myeloid leukaemia. Haematologica 2003; 88: 497–508
   PubMed Web of Science ®Google Scholar
• Feller N, van der Pol M A, van Stijn A, Weijers G WD, Westra A H, Evertse B W, et al. MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukemia. Leukemia 2004; 18: 1380–1390
   PubMed Web of Science ®Google Scholar
• Bradbury D, Rogers S, Reilly I A, Kozlowski R, Russell N H. Role of autocrine and paracrine production of granulocyte-macrophage colony-stimulating factor and interleukin-1β in the autonomous growth of acute myeloblastic leukaemia cells-studies using purified CD34-positive cells. Leukemia 1992; 6: 562–566
   PubMed Web of Science ®Google Scholar
• Faderl S, Harris D, Van Q, Kantarjian H M, Talpaz M, Estrov Z. Geanulocyte-macrophage colony-stimulating factor (GM-CSF) induces antiapoptotic and proapoptotic signals in acute myeloid leukaemia. Blood 2003; 102: 630–637
   PubMed Web of Science ®Google Scholar
• Diaz S, Shmelkov S V, Lam G, Rafii S. VEGF (165) promotes survival of leukemic cells by Hsp90-mediated induction of Bcl-2 expression and apoptosis inhibition. Blood 2002; 99: 2532–2540
   PubMed Web of Science ®Google Scholar